FDA Guidance Waives Informed-Consent Rule For Some Diagnostic Studies

FDA took a step to reduce the burden of conducting in vitro diagnostic clinical studies, announcing it will effectively disregard, when appropriate, regulations requiring investigators to get permission from people to use their biological samples